2025 Flow Diverters Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Flow Diverters Industry Market Size Be by 2025?
In recent times, the market size of flow diverters has seen a swift expansion. The market is predicted to surge from $0.5 billion in 2024 to $0.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.7%. This growth during the historical period can be credited to factors such as the increasing occurrence of intracranial aneurysms globally, a surge in the implementation of endovascular procedures, increased physicians and patients awareness, a rise in global healthcare expenditures, and a growing preference for minimally invasive and outpatient procedures.

What's the Long-Term Growth Forecast for the Flow Diverters Market Size Through 2029?
The size of the flow diverters market is anticipated to experience swift expansion in the upcoming years, projecting a growth to $0.86 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. The predicted growth in the forecast budget can be credited to an escalating count of positive medical results and real-world proof, boosted investments in research and development, an enlarging elderly population, increased reimbursement allowances, rising occurrences of hypertension, and atherosclerosis. Key advancements in the forecast timeframe include progression in flow diverter appliance structure, assimilation of superior imaging methodologies, enhancements in bioabsorbable and biocompatible materials technology, deliveries system advancements, and personalized medicine developments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/flow-diverters-global-market-report

What Are the Key Growth Drivers Fueling the Flow Diverters Market Expansion?
The growth of the flow diverters market is anticipated to be boosted by the increasing occurrence of aneurysms. Aneurysms are typically manifested as abnormal pouches or protrusions from the blood vessel wall caused by its weakening. Factors such as an aging population and advancements in diagnostic technologies contribute to the increased occurrence of aneurysms since these facilitate more detections and cultivated awareness, thereby magnifying the count of diagnosed cases. In addressing the escalating occurrence of aneurysms, flow diverters play a pivotal role by re-routing the blood flow away from the enfeebled vessel region, fostering healing, diminishing the chances of a rupture, and providing a less invasive substitute to conventional surgical interventions. For example, the Brain Aneurysm Foundation, a U.S.-based advocate group, reported in February 2022 that an approximated 6.5 million Americans, constituting nearly 1 in 50 individuals, harbor an unruptured brain aneurysm, with roughly 30,000 undergoing a rupture each year. Therefore, the increasing occurrence of aneurysms fuels the advancement of the flow diverters market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24539&type=smp

What Are the Key Trends Driving Flow Diverters Market Growth?
Key players in the flow diverters market are prioritizing advancements in materials science, including the development of polymer-based neurovascular stents to boost device performance, enhance biocompatibility, foster organic vessel repair, and lessen the dependence on long-term anticoagulant medication. A neurovascular stent made of polymer is a medical insertion engineered to sustain the openness of neurovasculature and is notably used in the treatment of aneurysms, stenosis, or vascular deformities. For example, fluid Biomed, a medical device startup based in Canada, unveiled the world's first insertion of a polymer neurovascular stent into human patients in June 2023. This ground-breaking device, dubbed the ReSolv stent, is customized to treat brain aneurysms. Uniquely, the ReSolv stent is totally polymer-based, unlike the typical hybrid polymer-metal stents, and is designed to slowly degrade as the blood vessel recovers. This innovative design could potentially lessen the need for long-term anticoagulant medication whilst aiding the blood vessel's natural healing cycle.

How Is the Flow Diverters Market Segmented?
The flow diverters market covered in this report is segmented -

1) By Type: Pipeline Embolization Device, Silk Flow Diverter, Surpass Flow Diverter, Flow Redirection Endoluminal Device, Other Types
2) By Material: Nitinol, Cobalt-Chromium Alloy, Stainless Steel, Other Materials
3) By Application: Intracranial Aneurysms, Arteriovenous Malformations, Carotid Artery Disease, Other Applications
4) By End-User: Hospital And Clinics, Ambulatory Surgical Centre

Subsegments:
1) By Pipeline Embolization Device: Classic Pipeline Embolization Device, Pipeline Flex Embolization Device, Pipeline Shield Technology
2) By Silk Flow Diverter: Silk+ Flow Diverter, Silk Vista Baby
3) By Surpass Flow Diverter: Surpass Streamline, Surpass Evolve
4) By Flow Redirection Endoluminal Device: FRED Jr., FRED X
5) By Other Types: DERIVO Embolization Device, p64 Flow Modulation Device, Tubridge Flow Diverter

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24539&type=smp

Which Companies Are Leading the Charge in Flow Diverters Market Innovation?
Major companies operating in the flow diverters market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., InspireMD Inc., INVAMED Medical Innovation, Oxford Endovascular Ltd., Qvanteq AG, EndoStream Medical Ltd., Endomimetics LLC.

Which Regions Are Leading the Global Flow Diverters Market in Revenue?
North America was the largest region in the flow diverters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the flow diverters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24539

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.